A renaissance in targeting the PI3K/AKT/mTOR pathway

Nature Reviews Drug Discovery 2026

View at publisher
Authors: Sarah E. Conduit, Neil Vasan, Jennifer R. Brown, Matthew W. D. Perry, Bart Vanhaesebroeck
DOI: 10.1038/s41573-026-01388-5
Cited by: 6
References: 337

Fields of Study & Subjects

PI3K/AKT/mTOR signaling in cancer Metabolism Diabetes and Cancer Histone Deacetylase Inhibitors Research

Publication details

Journal / source
Nature Reviews Drug Discovery
Publisher
Springer Science and Business Media LLC
Volume
25
Issue
6
Pages
469–493
Publication date
30 March 2026
Language
EN